# Schedules of Controlled Substances: Placement of MAB-CHMINACA in Schedule I
> **Rule** · Final rule. · Published 2019-01-29 · 84 FR 444
## Document
- **Document number:** 2019-00254
- **Category:** scheduling
- **Type:** Rule
- **Action:** Final rule.
- **Citation:** 84 FR 444
- **Publication date:** 2019-01-29
## Abstract

The Drug Enforcement Administration places N-(1-amino-3,3- dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3- carboxamide (MAB-CHMINACA; ADB-CHMINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action continues the imposition of the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle MAB-CHMINACA.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2019/01/29/2019-00254/schedules-of-controlled-substances-placement-of-mab-chminaca-in-schedule-i)
---
*AI Analytics · CC0 1.0*